ICU Medical Inc (ICUI)

144.55
NASDAQ : Health Care
Prev Close 145.10
Day Low/High 144.40 / 147.03
52 Wk Low/High 85.56 / 154.80
Avg Volume 160.50K
Exchange NASDAQ
Shares Outstanding 16.33M
Market Cap 2.37B
EPS 2.80
P/E Ratio 42.06
Div & Yield N.A. (N.A)

Latest News

ICUI Crosses Above Average Analyst Target

ICUI Crosses Above Average Analyst Target

In recent trading, shares of ICU Medical, Inc. have crossed above the average analyst 12-month target price of $142.50, changing hands for $142.80/share.

ICU Medical (ICUI) Stock Closed Higher on $1 Billion Pfizer Deal

ICU Medical (ICUI) Stock Closed Higher on $1 Billion Pfizer Deal

ICU Medical (ICUI) purchased Pfizer's (PFE) infusion therapy business for $1 billion,

Stocks Hold Mixed as Crude Settles Above $50, Wall Street Eyes Jobs Report

Stocks Hold Mixed as Crude Settles Above $50, Wall Street Eyes Jobs Report

Stocks hold mixed on Thursday afternoon as crude oil enjoys another rally and Wall Street looks toward the Friday release of the monthly jobs report.

ICU Medical Deal No Game Changer for Pfizer

The deal will close in the first quarter.

ICU Medical Inc. To Acquire The Hospira Infusion Systems Business from Pfizer Inc. For $1 Billion In Cash And Stock

ICU Medical Inc. To Acquire The Hospira Infusion Systems Business from Pfizer Inc. For $1 Billion In Cash And Stock

The addition of Hospira's IV pumps, solutions, and devices business to ICU Medical's existing portfolio will create a leading pure-play infusion therapy company

Strong And Under The Radar: ICU Medical (ICUI)

Strong And Under The Radar: ICU Medical (ICUI)

Trade-Ideas LLC identified ICU Medical (ICUI) as a strong and under the radar candidate

Noteworthy Friday Option Activity: ICUI, CONN, ITCI

Noteworthy Friday Option Activity: ICUI, CONN, ITCI

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in ICU Medical, Inc. , where a total of 1,022 contracts have traded so far, representing approximately 102,200 underlying shares.

ICU Medical, Inc. Announces Fourth Quarter And Fiscal Year 2015 Results

ICU Medical, Inc. Announces Fourth Quarter And Fiscal Year 2015 Results

Fiscal Year 2015 Adjusted EBITDA Increased 54% to $114 Million

New Study Shows ICU Medical's SwabCap® Reduced Central Line-Associated Bloodstream Infections And Blood Culture Contamination, Corresponding To $3.2 Million Annual Savings

New Study Shows ICU Medical's SwabCap® Reduced Central Line-Associated Bloodstream Infections And Blood Culture Contamination, Corresponding To $3.2 Million Annual Savings

In commenting on the peer-reviewed study by clinicians at New York City's Memorial Sloan Kettering Cancer Center, an editor for the New England Journal of Medicine noted that use of these devices could "markedly outweigh the added cost" in most institutions.

Today's Perilous Reversal Stock: ICU Medical (ICUI)

Today's Perilous Reversal Stock: ICU Medical (ICUI)

Trade-Ideas LLC identified ICU Medical (ICUI) as a "perilous reversal" (up big yesterday but down big today) candidate

ICU Medical Partners With Medline Industries To Acquire Excelsior Medical Corporation

ICU Medical Partners With Medline Industries To Acquire Excelsior Medical Corporation

Acquisition Expands Company's Direct and OEM Infusion Therapy Businesses

New Lifetime High Today: ICU Medical (ICUI)

New Lifetime High Today: ICU Medical (ICUI)

Trade-Ideas LLC identified ICU Medical (ICUI) as a new lifetime high candidate

ICU Medical (ICUI) Highlighted As Strong And Under The Radar Stock Of The Day

ICU Medical (ICUI) Highlighted As Strong And Under The Radar Stock Of The Day

Trade-Ideas LLC identified ICU Medical (ICUI) as a strong and under the radar candidate

Trade-Ideas: ICU Medical (ICUI) Is Today's Strong And Under The Radar Stock

Trade-Ideas: ICU Medical (ICUI) Is Today's Strong And Under The Radar Stock

Trade-Ideas LLC identified ICU Medical (ICUI) as a strong and under the radar candidate